FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

775027002: Product containing only canakinumab (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3730106012 Canakinumab only product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3730107015 Product containing only canakinumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3730106012 Canakinumab only product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3730107015 Product containing only canakinumab (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5717251000241112 produit contenant seulement canakinumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
512861000188119 médicament contenant seulement canakinumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
5717251000241112 produit contenant seulement canakinumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Canakinumab only product Is a Product containing canakinumab (medicinal product) true Inferred relationship Existential restriction modifier (core metadata concept)
Canakinumab only product Count of base of active ingredient un false Inferred relationship Existential restriction modifier (core metadata concept)
Canakinumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Canakinumab (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only canakinumab in parenteral dose form (medicinal product form) Is a True Canakinumab only product Inferred relationship Existential restriction modifier (core metadata concept)

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start